GGrantIndex
← Leaderboards

Misty L Good

University Of Pittsburgh At Pittsburgh

$6,378,808
Attributed
$8,815,829
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,815,829 · 6

By mechanism

R01$6,629,409 · 3
DP1$1,450,206 · 1
K08$583,714 · 1
R03$152,500 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Inflammatory Response

Research focus

Inflammatory ResponsePremature InfantNecrotizing EnterocolitisPathogenesisIntestinesInfantGastrointestinal DiseasesIntestinal EpitheliumCytokineDesignPreventInflammatoryNecrosisOperative Surgical ProceduresMortalityInnovationPathogenicityCellsPremature Infant DiseasesExcisionEpithelial CellsPhenotypeMorbidity - Disease RateAffect

Grant awards (24)

Reprogramming intestinal immunity in preterm neonates to prevent and cure necrotizing enterocolitis$725,129
DP1 · FY2025 · DK · contact PI
Reprogramming intestinal immunity in preterm neonates to prevent and cure necrotizing enterocolitis$725,077
DP1 · FY2024 · DK · contact PI
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine$566,175
R01 · FY2024 · HD · contact PI
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis$560,545
R01 · FY2024 · DK · contact PI
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine$603,596
R01 · FY2023 · HD · contact PI
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis$589,942
R01 · FY2023 · DK · contact PI
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis$641,955
R01 · FY2022 · DK · contact PI
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine$590,140
R01 · FY2022 · HD · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$345,740
R01 · FY2022 · DK · contact PI
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitis$686,955
R01 · FY2021 · DK · contact PI
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine$538,051
R01 · FY2021 · HD · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$233,250
R01 · FY2021 · DK · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$118,125
R01 · FY2021 · DK · contact PI
Neonatal gut-on-a-chip platform for high content drug testing and precision medicine$96,684
R01 · FY2021 · HD · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$354,375
R01 · FY2020 · DK · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$353,438
R01 · FY2019 · DK · contact PI
Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis$350,438
R01 · FY2018 · DK · contact PI
Aryl hydrocarbon receptor signaling in the pathogenesis of necrotizing enterocolitis$76,250
R03 · FY2018 · DK · contact PI
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis$146,307
K08 · FY2017 · DK · contact PI
Aryl hydrocarbon receptor signaling in the pathogenesis of necrotizing enterocolitis$76,250
R03 · FY2017 · DK · contact PI
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis$127,955
K08 · FY2016 · DK · contact PI
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis$15,952
K08 · FY2016 · DK · contact PI
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis$146,750
K08 · FY2015 · DK · contact PI
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing Enterocolitis$146,750
K08 · FY2014 · DK · contact PI